STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Beschikbaar vanaf:

Sanofi-Aventis Australia Pty Ltd

INN (Algemene Internationale Benaming):

prochlorperazine mesilate

farmaceutische vorm:

Injection

Samenstelling:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Toedieningsweg:

Intramuscular

Eenheden in pakket:

10 x 1 mL

Prescription-type:

(S1) This Schedule is intentionally blank

therapeutische indicaties:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Product samenvatting:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Autorisatie-status:

Licence status A

Autorisatie datum:

2007-07-16